Discover
ACTU
Actuate Therapeutics, Inc. Common stock
0.34
2 x 0.80
2 x 1.45
bid
ask
-
0.04
9.68%
2 @ 04:00 PM
0.34 -0.00 (0.03%)
| Ytd | -94.52% | |
| 1y | -94.91% |
0.34
day range
0.39
0.34
52 week range
7.90
| Open | 0.38 | Prev Close | 0.37 | Low | 0.34 | High | 0.39 | Mkt Cap | 18.43M |
| Vol | 489.47K | Avg Vol | 408.68K | EPS | -0.87 | P/E | N/A | Forward P/E | N/A |
| Beta | N/A | Short Ratio | 0.49 | Inst. Own | 53.05% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 0.92 | 200-d Avg | 2.18 | 1yr Est | 0.00 |
| Income Statement | |||
| Operating Expenses | 4.91M | ||
| Research and Development Expense | 2.07M | ||
| Selling, General and Administrative Expense | 2.84M | ||
| Operating Income | -4.91M | ||
| Interest Expense | 5.06K | ||
| Net Income | -4.87M | ||
| Net Income Common Stock | -4.87M | ||
| Net Income Common Stock (USD) | -4.87M | ||
| Consolidated Income | -4.87M | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -4.86M | ||
| Earning Before Interest & Taxes (USD) | -4.86M | ||
| Weighted Average Shares | 23.87M | ||
| Weighted Average Shares Diluted | 23.87M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.43M | ||
| Cash and Equivalents (USD) | 4.43M | ||
| Current Assets | 4.75M | ||
| Total Assets | 5.20M | ||
| Current Liabilities | 3.81M | ||
| Total Liabilities | 4.21M | ||
| Accumulated Retained Earnings (Deficit) | -165.10M | ||
| Shareholders Equity | 989.15K | ||
| Shareholders Equity (USD) | 989.15K | ||
| Assets Non-Current | 451.40K | ||
| Liabilities Non-Current | 404.99K | ||
| Trade and Non-Trade Payables | 1.48M | ||
| Cash Flow | |||
| Net Cash Flow from Financing | 696.96K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -3.71M | ||
| Issuance (Purchase) of Equity Shares | 731.59K | ||
| Net Cash Flow from Operations | -4.41M | ||
| Share Based Compensation | 1.34M | ||